Education
About Us
Working with TipRanks
Follow Us
Lincoln Pharmaceuticals Ltd (IN:LINCOLN)
:LINCOLN
LINCOLN Stock Chart & Stats
₹496.60
-₹14.55(-1.74%)
At close: 4:00 PM EST
₹496.60
-₹14.55(-1.74%)
Day’s Range― - ―
52-Week Range₹439.95 - ₹679.45
Previous CloseN/A
Volume57.32K
Average Volume (3M)1.66K
Market Cap
₹11.99B
Enterprise Value₹11.79B
Total Cash (Recent Filing)₹2.32B
Total Debt (Recent Filing)₹668.00K
Price to Earnings (P/E)8.5
Beta1.32
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.37%
Share Statistics
EPS (TTM)14.28
Shares Outstanding20,029,728
10 Day Avg. Volume3,133
30 Day Avg. Volume1,664
Financial Highlights & Ratios
PEG Ratio-1.14
Price to Book (P/B)1.65
Price to Sales (P/S)1.77
P/FCF Ratio14.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Near-zero Debt Balance SheetA near-zero debt profile and growing equity base provide durable financial flexibility: low solvency risk, capacity to fund capex or M&A from internal resources, and resilience in downturns. This structural conservatism reduces refinancing and interest-rate exposure over months.
Rebound In Free Cash FlowA meaningful rebound in free cash flow that now covers a large share of net income signals stronger cash conversion and capacity to self-fund growth, dividends, or deleveraging. Sustained FCF supports long-term investment flexibility and lowers external financing dependence.
Steady Revenue Growth And Healthy Gross MarginsConsistent top-line expansion paired with gross margins above 50% indicate durable product economics and pricing power in core formulations. Over 2–6 months this supports reinvestment into commercial reach and R&D, and provides buffer versus input cost swings.
Bears Say
Recent Margin CompressionDeclining EBITDA and net margins suggest rising cost pressures or weaker pricing that can persistently reduce earnings power unless addressed. If structural (input costs, pricing pressure, mix shift), compressed margins will limit cash available for reinvestment and shareholder returns over months.
Operating Cash Flow Below Net IncomeOSCF consistently trailing net income signals working-capital swings or receivables/inventory timing that can strain liquidity unpredictably. This variability increases reliance on careful working-capital management and can impair the predictability of free cash flow generation in the medium term.
Earnings Growth And ROE ModerationNegative EPS growth and a falling ROE indicate pressure on profitability or capital efficiency. If earnings and returns on equity remain subdued versus past levels, it may constrain reinvestment returns, slow shareholder-value creation, and reflect structural margin or competitive headwinds.
Lincoln Pharmaceuticals Ltd News
LINCOLN FAQ
What was Lincoln Pharmaceuticals Ltd’s price range in the past 12 months?
Lincoln Pharmaceuticals Ltd lowest stock price was ₹439.95 and its highest was ₹679.45 in the past 12 months.
What is Lincoln Pharmaceuticals Ltd’s market cap?
Lincoln Pharmaceuticals Ltd’s market cap is ₹11.99B.
When is Lincoln Pharmaceuticals Ltd’s upcoming earnings report date?
Lincoln Pharmaceuticals Ltd’s upcoming earnings report date is May 21, 2026 which is in 63 days.
How were Lincoln Pharmaceuticals Ltd’s earnings last quarter?
Lincoln Pharmaceuticals Ltd released its earnings results on Feb 12, 2026. The company reported ₹14.279 earnings per share for the quarter, beating the consensus estimate of N/A by ₹14.279.
Is Lincoln Pharmaceuticals Ltd overvalued?
According to Wall Street analysts Lincoln Pharmaceuticals Ltd’s price is currently Overvalued.
Does Lincoln Pharmaceuticals Ltd pay dividends?
Lincoln Pharmaceuticals Ltd pays a Annually dividend of ₹1.8 which represents an annual dividend yield of 0.37%. See more information on Lincoln Pharmaceuticals Ltd dividends here
What is Lincoln Pharmaceuticals Ltd’s EPS estimate?
Lincoln Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lincoln Pharmaceuticals Ltd have?
Lincoln Pharmaceuticals Ltd has 20,029,728 shares outstanding.
What happened to Lincoln Pharmaceuticals Ltd’s price movement after its last earnings report?
Lincoln Pharmaceuticals Ltd reported an EPS of ₹14.279 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 15.516%.
Which hedge fund is a major shareholder of Lincoln Pharmaceuticals Ltd?
Currently, no hedge funds are holding shares in IN:LINCOLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.
Technical Analysis
Kilitch Drugs (India) Limited
―
Kopran Limited
―
Themis Medicare Limited
―
Wanbury Limited
―
Anuh Pharma Limited
―